MARKET

XBIT

XBIT

Xbiotech
NASDAQ
3.620
+0.040
+1.12%
Closed 16:00 09/30 EDT
OPEN
3.605
PREV CLOSE
3.580
HIGH
3.670
LOW
3.558
VOLUME
38.98K
TURNOVER
84.84K
52 WEEK HIGH
16.47
52 WEEK LOW
3.550
MARKET CAP
110.19M
P/E (TTM)
-4.1034
1D
5D
1M
3M
1Y
5Y
XBiotech (NASDAQ:XBIT) shareholders have endured a 73% loss from investing in the stock a year ago
As every investor would know, you don't hit a homerun every time you swing. But it would be foolish to simply accept...
Simply Wall St. · 09/08 12:59
We Think XBiotech (NASDAQ:XBIT) Can Afford To Drive Business Growth
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Simply Wall St. · 08/12 12:38
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
Here's a roundup of top developments in the biotech space over the last 24 hours:
Benzinga · 06/21 13:03
BRIEF-XBiotech Announces Successful Completion Of Phase I Portion Of Pancreatic Cancer Study
BRIEF-XBiotech Announces Successful Completion Of Phase I Portion Of Pancreatic Cancer Study
Reuters · 06/20 13:16
XBiotech Announces Successful Completion of Phase I portion of Pancreatic Cancer Study
Novel Natrunix Treatment Shows Promise in Combination Chemotherapy for Treatment of Pancreatic CancerAUSTIN, Texas, June 20, 2022 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today it successfully completed the Phase I portion of its 1-BETTER...
GlobeNewswire · 06/20 13:00
Could The XBiotech Inc. (NASDAQ:XBIT) Ownership Structure Tell Us Something Useful?
The big shareholder groups in XBiotech Inc. ( NASDAQ:XBIT ) have power over the company. Generally speaking, as a...
Simply Wall St. · 05/24 13:06
Stocks That Hit 52-Week Lows On Monday
  On Monday, 198 companies reached new 52-week lows.
Benzinga · 05/16 17:59
Why Are XBiotech Shares Trading Higher Today
Benzinga · 04/28 18:53
More
About XBIT
XBiotech Inc. is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies for treating a variety of diseases. The Company is focused on the therapies that block a potent substance naturally produced by body, known as interleukin-1 alpha (IL-1a), that mediates tissue breakdown, angiogenesis, the formation of blood clots and inflammation. IL-1a is a protein that is on or in cells of the body and is involved in the body’s response to injury or trauma. Its True Human antibodies have the potential to harness the body's natural immunity to fight disease with increased safety, efficacy and tolerability. The Company has developed a pipeline of product candidates targeting both inflammatory and infectious diseases. The Company is developing a pipeline of product candidates targeting both inflammatory and infectious diseases and has developed commercial scale manufacturing technology and infrastructure.

Webull offers kinds of XBiotech Inc stock information, including NASDAQ:XBIT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XBIT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XBIT stock methods without spending real money on the virtual paper trading platform.